Stay updated with breaking news from Clinformatics Data Mart Database. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The average number of inappropriate antibiotics prescribed monthly decreased at the start of the COVID-19 pandemic but returned to pre-pandemic levels by late 2021, data show.
Proposed national $35 insulin cap would help some patients, researchers say
The association between SGLT2i use and kidney stone risk was similar by race and ethnicity, sex, obesity, and history of chronic kidney disease. Use of an SGLT2 inhibitor instead of other classes of glucose-lowering agents is associated with lower kidney stone risk.
Adult patients with type 2 diabetes (T2D) who use a sodium-glucose cotransporter 2 inhibitor (SGLT2i) rather than other classes of glucose-lowering agents Use of an SGLT2 inhibitor instead of other classes of glucose-lowering agents is associated with lower kidney stone risk.
Use of an SGLT2 inhibitor instead of other classes of glucose-lowering agents is associated with lower kidney stone risk. Use of an SGLT2 inhibitor instead of other classes of glucose-lowering agents is associated with lower kidney stone risk.